share_log

AnPac Bio Announces Board and Management Changes,

Benzinga Real-time News ·  Oct 3, 2022 17:21

AnPac Bio-Medical Science Co., Ltd. (NASDAQ:ANPC) ("AnPac Bio" or the "Company"), a biotechnology company with operations in the United States and China focused on early cancer screening and detection, today announced changes to its board composition and management team.

Mr. Haohan Xu has been appointed as a director of the board of directors (the "Board"), Co-Chairperson of the Board and Co-Chief Executive Officer of the Company. Mr. Xu is the Chief Executive Officer of Apifiny Group Inc., a digital asset trading infrastructure provider based in New York, United States and has been actively engaged in the...

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment